Lacimto Tablet

Lacimto Tablet contains Calcium acetate as its active ingredient. It is primarily prescribed to manage hyperphosphatemia, a condition marked by elevated phosphate levels in the blood, commonly seen in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing dialysis. By binding to dietary phosphate in the digestive tract, it helps reduce phosphate absorption, improving bone health and lowering the risk of bone pain, fractures, and skeletal complications. Lacimto Tablet reduces phosphate buildup, supports bone strength, and minimises the risk of cardiovascular issues such as blood vessel calcification. It can also relieve symptoms like itching and skin irritation often associated with kidney disease. It is mainly prescribed to control phosphate levels as part of a broader kidney care plan, often alongside dietary modifications. Possible side effects may include nausea, constipation, or stomach discomfort. Use this medication under medical supervision and report any allergic reactions or unusual symptoms immediately. The price may vary depending on brand and availability.

The Lacimto Tablet is used in the treatment of the following: Hyperphosphatemia in CKD/ESRD Adjunct to dietary management in CKD/ESRD dialysis.

Lacimto Tablet's therapeutic action is its ability to bind with dietary phosphate in the gastrointestinal tract. Upon ingestion, it dissociates into calcium and acetate ions. The calcium ions form insoluble complexes with phosphate ions from ingested foods, forming calcium phosphate salts that are not absorbed into the bloodstream. As a result, phosphate absorption from the diet is reduced, leading to lower phosphate levels in the blood.

Lacimto Tablet is typically administered orally, meaning it is taken by mouth as tablets or capsules. The medication is designed to be swallowed with water and should not be chewed or crushed unless specifically instructed by a healthcare provider. The oral route is the most common and effective way to use this medication to manage hyperphosphatemia in individuals with chronic kidney and end-stage renal disease.

Lacimto Tablet cause some side effects like all medications, although not everyone will experience them. Serious side effects of Lacimto Tablet are: Hypercalcemia Calcium-based tissue deposition Aluminum toxicity Common side effects of Lacimto Tablet are: Upset stomach Constipation Abdominal pain Loss of appetite Itching Hypocalcemia.

Inform your healthcare provider about your complete medical history, allergies, and any ongoing medications or supplements before starting treatment to ensure safe use. Regular monitoring of blood phosphate levels is essential to evaluate the effectiveness of Lacimto Tablet in managing hyperphosphatemia. Follow the dietary recommendations provided by your healthcare provider to enhance the medication’s effectiveness. Watch for symptoms of electrolyte imbalance, such as: Hypercalcemia: nausea, vomiting, and confusion. Hypocalcemia: muscle cramps, tingling, or weakness. Consult your doctor immediately if you experience any adverse effects — your physician may adjust your dosage or suggest an alternative treatment. Pregnant and breastfeeding individuals should seek medical advice before using this medication. Discuss any allergies, past hypersensitivity reactions, or underlying liver or lung conditions with your healthcare provider before starting therapy. Always consult your healthcare provider for personalized advice and safe, effective use of this medicine based on your specific health needs.